In a research report published Monday, Cantor analyst Mara Goldstein maintained a Hold rating on ImmunoGen (NASDAQ:IMGN) and reduced her price target to $9 (from $14), …
In a research report issued today, Cantor analyst Mara Goldstein maintained a Buy rating on shares of Celldex Therapeutics (NASDAQ:CLDX) with a $33 price …
In a research report published this morning, Cantor analyst Mara Goldstein reiterated a Buy rating on Array Biopharma (NASDAQ:ARRY) with a $9.00 price target, as …
In a research report released earlier today, Cantor analyst Mara Goldstein upgraded shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) from Hold to Buy and doubled her …
In a research report issued today, Cantor analyst Mara Goldstein reiterated a Buy rating on Celgene Corporation (NASDAQ:CELG) and raised her price target …
In a research report released Thursday, Cantor analyst Mara Goldstein maintained a Buy rating on Array BioPharma (NASDAQ:ARRY) with a $9 price target, as the …
In a research report issued today, Cantor analyst Mara Goldstein maintained a Buy rating on Newlink Genetics (NASDAQ:NLNK) with a $48 price target, as …
In a research note published this morning, Cantor Fitzgerald analyst Mara Goldstein maintained a Hold rating on Sunesis Pharmaceuticals (NASDAQ:SNSS) with a $2 …
